Adamu Alhamdu, Chen Rui, Li An, Xue Guofang
The Second Affiliated Hospital of Shanxi Medical University, Shanxi, 030001, Taiyuan, China.
Department of Neurology, The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, 030001, China.
Acta Epileptol. 2023 Oct 13;5(1):25. doi: 10.1186/s42494-023-00136-1.
Epilepsy affects 50 million people worldwide. Nearly 80% of people with epilepsy live in resource-constrained low-income and middle-income countries. In Asia, which has a population of over 4 billion or has 50% of the world's population, about 23 million people have epilepsy. In this review, we discuss the difficulties in managing epilepsy in Asia due to the limited resources. The medical expense, limited access to treatment, premature mortality, health transitions from pediatric care to adult care, and the huge population size make it challenging for epilepsy management. Even though certain countries have access to highly innovative treatments, up to 90% of patients with epilepsy do not receive proper care due to limited resources. The insufficiency of research on epilepsy in most countries makes it difficult to obtain accurate data to analyze the progress of epilepsy management. However, the current influx of research studies, acceptance of the latest international practices, and funding will contribute a long way to closing treatment gaps in communities.
癫痫影响着全球5000万人。近80%的癫痫患者生活在资源有限的低收入和中等收入国家。亚洲人口超过40亿，占世界人口的50%，约有2300万人患有癫痫。在本综述中，我们讨论了由于资源有限，亚洲在癫痫管理方面存在的困难。医疗费用、治疗机会有限、过早死亡、从儿科护理向成人护理的健康过渡以及庞大的人口规模，使得癫痫管理具有挑战性。尽管某些国家能够获得高度创新的治疗方法，但由于资源有限，高达90%的癫痫患者无法得到适当的护理。大多数国家对癫痫的研究不足，难以获得准确数据来分析癫痫管理的进展。然而，目前大量的研究、对最新国际实践的接受以及资金投入，将在很大程度上有助于缩小社区的治疗差距。
